ASCO GUIDELINES Bundle

Fever and Neutropenia (ASCO)

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/284307

Contents of this Issue

Navigation

Page 11 of 11

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies: info@GuidelineCentral.com Copyright © 2013 All rights reserved Disclaimer is resource is a practice tool for physicians based on an ASCO ® practice guideline. e practice guideline and this tool are not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients and may not reflect the most recent evidence. is tool does not recommend any particular product or course of medical treatment. Use of the practice guideline and this resource is voluntary. e full practice guideline and additional information are available at http://www.asco.org/guidelines. Copyright © 2013 by American Society of Clinical Oncology ® . All rights reserved. Abbreviations ALC, absolute lymphocyte count; AMC, absolute monocyte count; ANC, absolute neutrophil count; ASCO, American Society of Clinical Oncolog y; CHOP, cyclophosphamide, hydroxydaunorubicin (doxorubicin), vincristine (Oncovin ™ ), prednisone; CNS, central nervous system; CR, complete response; ECOG, Eastern Cooperative Oncolog y Group; FN, febrile neutropenia; FNE, febrile neutropenic event; Hb, hemoglobin; Hct, hematocrit; hr, hour; IDSA, Infectious Diseases Society of America; IFI, invasive fungal infections; IV, intravenous; MASCC, Multinational Association for Supportive Care in Cancer; MDS, myelodysplastic syndromes; NCI, National Cancer Institute; NHL, non-Hodgkin's lymphoma; OMAS, oral mucositis assessment scale; PR, partial response; PS, performance status; ULN, upper limit of normal; WBC, white blood cell Source Flowers CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncolog y clinical practice guideline. J Clin Oncol. 2013 Jan 14. [Epub ahead of print]. ASCOFEV130702d Table 6. ECOG Performance Status a Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, eg, light house work, office work 2 Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours 3 Capable of only limited self-care. Confined to bed or chair more than 50% of waking hours 4 Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair 5 Dead a Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncolog y Group. Am J Clin Oncol. 1982;5:649-655. Acknowledgement: Eastern Cooperative Oncolog y Group, Robert Comis, MD, Group Chair.

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Fever and Neutropenia (ASCO)